Logo image of NEUE

NEUEHEALTH INC (NEUE) Stock Fundamental Analysis

USA - NYSE:NEUE - US10920V4041 - Common Stock

6.753 USD
+0.08 (+1.24%)
Last: 10/1/2025, 9:16:12 PM
6.73 USD
-0.02 (-0.34%)
Pre-Market: 10/2/2025, 7:32:06 AM
Fundamental Rating

2

Overall NEUE gets a fundamental rating of 2 out of 10. We evaluated NEUE against 101 industry peers in the Health Care Providers & Services industry. NEUE has a bad profitability rating. Also its financial health evaluation is rather negative. NEUE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NEUE had negative earnings in the past year.
NEUE had a negative operating cash flow in the past year.
In the past 5 years NEUE always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: NEUE reported negative operating cash flow in multiple years.
NEUE Yearly Net Income VS EBIT VS OCF VS FCFNEUE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -18.13%, NEUE is doing worse than 81.19% of the companies in the same industry.
Industry RankSector Rank
ROA -18.13%
ROE N/A
ROIC N/A
ROA(3y)-54.73%
ROA(5y)-42.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NEUE Yearly ROA, ROE, ROICNEUE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200 300

1.3 Margins

NEUE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NEUE Yearly Profit, Operating, Gross MarginsNEUE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

More info and screens

3

2. Health

2.1 Basic Checks

NEUE does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEUE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NEUE has been increased compared to 5 years ago.
The debt/assets ratio for NEUE is higher compared to a year ago.
NEUE Yearly Shares OutstandingNEUE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NEUE Yearly Total Debt VS Total AssetsNEUE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

NEUE has an Altman-Z score of -6.94. This is a bad value and indicates that NEUE is not financially healthy and even has some risk of bankruptcy.
NEUE has a worse Altman-Z score (-6.94) than 91.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.94
ROIC/WACCN/A
WACC6%
NEUE Yearly LT Debt VS Equity VS FCFNEUE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

2.3 Liquidity

NEUE has a Current Ratio of 2.70. This indicates that NEUE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.70, NEUE belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
NEUE has a Quick Ratio of 2.70. This indicates that NEUE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.70, NEUE belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.7
Quick Ratio 2.7
NEUE Yearly Current Assets VS Current LiabilitesNEUE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

NEUE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.23%.
Looking at the last year, NEUE shows a very negative growth in Revenue. The Revenue has decreased by -13.83% in the last year.
The Revenue has been growing by 27.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-87.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.89%
Revenue 1Y (TTM)-13.83%
Revenue growth 3Y-14.76%
Revenue growth 5Y27.26%
Sales Q2Q%-7.48%

3.2 Future

Based on estimates for the next years, NEUE will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.62% on average per year.
The Revenue is expected to grow by 16.81% on average over the next years. This is quite good.
EPS Next Y14%
EPS Next 2Y11.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.84%
Revenue Next 2Y16.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NEUE Yearly Revenue VS EstimatesNEUE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
NEUE Yearly EPS VS EstimatesNEUE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NEUE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NEUE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEUE Price Earnings VS Forward Price EarningsNEUE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEUE Per share dataNEUE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEUE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEUEHEALTH INC

NYSE:NEUE (10/1/2025, 9:16:12 PM)

Premarket: 6.73 -0.02 (-0.34%)

6.753

+0.08 (+1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners51.44%
Inst Owner ChangeN/A
Ins Owners11.99%
Ins Owner Change-755.62%
Market Cap60.91M
Revenue(TTM)890.44M
Net Income(TTM)-134798000
Analysts42.86
Price Target7.14 (5.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)86.36%
Min EPS beat(2)61.7%
Max EPS beat(2)111.02%
EPS beat(4)3
Avg EPS beat(4)55.87%
Min EPS beat(4)-23.97%
Max EPS beat(4)111.02%
EPS beat(8)4
Avg EPS beat(8)68.26%
EPS beat(12)6
Avg EPS beat(12)40.72%
EPS beat(16)6
Avg EPS beat(16)0.91%
Revenue beat(2)0
Avg Revenue beat(2)-31.77%
Min Revenue beat(2)-33.05%
Max Revenue beat(2)-30.49%
Revenue beat(4)0
Avg Revenue beat(4)-18.95%
Min Revenue beat(4)-33.05%
Max Revenue beat(4)-2.77%
Revenue beat(8)1
Avg Revenue beat(8)-12.15%
Revenue beat(12)2
Avg Revenue beat(12)-15.49%
Revenue beat(16)2
Avg Revenue beat(16)-38.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.16
EYN/A
EPS(NY)-14.9
Fwd EYN/A
FCF(TTM)-8.23
FCFYN/A
OCF(TTM)-7.77
OCFYN/A
SpS98.72
BVpS-49.75
TBVpS-57.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.73%
ROA(5y)-42.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.87%
Cap/Sales 0.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.7
Quick Ratio 2.7
Altman-Z -6.94
F-Score4
WACC6%
ROIC/WACCN/A
Cap/Depr(3y)27.02%
Cap/Depr(5y)49%
Cap/Sales(3y)0.54%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.89%
EPS Next Y14%
EPS Next 2Y11.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.83%
Revenue growth 3Y-14.76%
Revenue growth 5Y27.26%
Sales Q2Q%-7.48%
Revenue Next Year28.84%
Revenue Next 2Y16.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.24%
OCF growth 3YN/A
OCF growth 5YN/A

NEUEHEALTH INC / NEUE FAQ

Can you provide the ChartMill fundamental rating for NEUEHEALTH INC?

ChartMill assigns a fundamental rating of 2 / 10 to NEUE.


What is the valuation status for NEUE stock?

ChartMill assigns a valuation rating of 0 / 10 to NEUEHEALTH INC (NEUE). This can be considered as Overvalued.


How profitable is NEUEHEALTH INC (NEUE) stock?

NEUEHEALTH INC (NEUE) has a profitability rating of 0 / 10.


What is the financial health of NEUEHEALTH INC (NEUE) stock?

The financial health rating of NEUEHEALTH INC (NEUE) is 3 / 10.